About this trial
This study looks at patients with esophageal cancer who have had surgery to remove their tumors. It focuses on how the distance of any remaining tumor from the edge of the removed tissue affects their future health. The goal is to understand better how this distance can impact patient outcomes after surgery.
The trial ID is NCT05706558. It is not a drug or device trial regulated by the FDA, and it aims to include about 4,000 participants.
Who can join
Men and women aged 18 and older can join if they have a specific type of esophageal cancer and have had surgery. Those with different cancer types, earlier-stage tumors, or certain other conditions cannot participate. The trial team will confirm who is eligible.
Conditions
Esophageal Cancer, Esophagus Cancer
Age group
Adult, Older adult
The study team makes the final call on eligibility.
What happens in the study
Participants will be grouped based on how close any remaining tumor is to the edge of the removed tissue. Everyone in the study has had surgery called esophagectomy to remove their tumors. The study will look at their health outcomes over time, up to two years after surgery.
Where
This trial is running at 1 location in the United States. It is currently recruiting.
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York